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PREVIOUSLY it was reported that a proprietary engine oil additive was carci-
nogenic following repeated skin painting in mice (Baldwin, Cunningham and Pratt,
1961). This additive, which is utilized as a high pressure, high temperature
lubricant, contains a formulation consisting mainly of lead naphthenate together
with small amounts of chlorinated hydrocarbons such as carbon tetrachloride or
1: 1: 1-trichlorethane dispersed in a mineral oil base. The various components
are themselves highly heterogeneous mixtures without any well defined charac-
teristics. Thus the lead naphthenate fraction is a subsidiary oil product
obtained during the manufacture of hydrocarbon distillates. This fraction,
which is of varying composition depending upon the source of crude oil, contains
lead salts of a complex mixture of aromatic and aliphatic carboxylic acids
(Knotnerus, 1957). Clearly therefore isolation and chemical characterization of
the carcinogenic component(s) in the proprietary oil additives, although desirable,
is not practical at this time. However it was considered essential to ascertain
whether the carcinogenic activity was associated with any one of the crude pro-
ducts,particularlyinviewofthevarietyofuses,e.g. paintdriers,woodpreservatives
and wettingagents, ofthenaphthenic acids. Accordingly, various components of
the oil additive, supplied by the manufacturer, have been assessedfor carcinogenic
activity following skin painting in mice. In addition, a second proprietary




Additive I.-Component fractions of the additive previously shown to be
carcinogenic for mouse skin (Baldwin, Cunningham and Pratt, 1961) were supplied
by the manufacturer.
(i) Base oil into which the additive is dispersed.
(ii) Additive formulation: The proprietary additive contains 10 per cent of
this formulation in base oil. For carcinogenic assay, the formulation was skin
painted as a 20 per cent v/v solution in double distilled AR benzene.
(iii) Lead naphthenate. This material, supplied as a dark brown oily liquid,
is one of the major components of the additive formulation. For carcinogenic
assay, the material was skin painted as a 20 per cent v/v solution in benzene.
Additive II.-A proprietary additive agent used mainly as an upper cylinder
lubricant. This was obtained commercially in sealed cans.
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EXPERIMENTAL PROCEDURE
Young adult male albino mice (Schofield strain) were employed in all tests.
They were maintained in groups of 20 on a standard cubed diet with water ad
libitum. Dorsal hair was removed with electric clippers at the beginning of each
test and then subsequently when necessary. Oil samples were applied dropwise to
the skin from all-glass tuberculin syringes and where necessary spread with glass
rods. Mice were treated once or twice weekly for periods ofup to 12 months and
the total dose applied is shown in Table I. Mice were examined for tumours at
weekly intervals unitil the tests were terminated (18 months) and were killed
whenthey were ill or when tumours were considered malignant. All tumours were
taken for histological examination and tumour incidences were assessed from the
number of mice surviving (at risk) when tumours were first observed.
RESULTS
The base oil fraction used in the additive previously shown to be carcinogenic
(additive I) proved to be highly toxic causing marked inflammatory changes in
skin similar to those observed with the whole additive. During the first 6 months
of treatment with this fraction, mice were skin painted twice weekly. However,
survival was poor, 16 of the original mice (40 per cent) dying or being killed
(Fig. 1)and therefore micewere treated thereafter onlyonce weeklyuntilskin pain-
ting wasterminated (12months). Neitheroftheothertwofractionsoftheadditive
showed any toxic properties towards skin and survival of treated mice was good
(Fig. 1) despite the fact that these substances were applied twice weekly at
concentrations double those in the whole additive.
The base oilfraction proved to be carcinogenic following repeated skin painting,
inducing skin tumours in 66 per cent of mice at risk (Table I). Although this
skin tumour incidence is comparable to that induced with the whole additive
(69 per cent), the majority oftumours were benign papillomata and squamous cell
carcinomata (Fig. 2) were observed in only 5 mice (17 per cent). This contrasts
with the high incidence of skin carcinomata induced by the whole additive (51
per cent).
Neither the whole additive formulation nor the lead naphthenate fraction
produced any significant carcinogenic response in mouse skin. Hence skin
TABLE I.-Skin Tumour Incidences in Mice Treated with Oil
Additives or Component Fractions
Skin tumour incidence
Time first -
Total Duration of tumour Number Total tumours Skin carcinomas
dose experiment observed of mice -A _
Fraction . (ml.) (days) (days) at risk Number Percentage Number Percentage
Additive I . 32 456 135 35 24 69 18 51
Additive II . 33 559 172 54 25 46 10 19
Additive I
components-
(i) Base oil . 21 493 68 29 19 66 5 17
(ii) Additive . 6* 570 245 32 1 3 0
concentrate
(iii) Lead . 6 648 193 59 2 4 0
naphthenate
* Equivalent to the amount contained in 60 ml. of whole additive.
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papillomata were observed in only 2 mice (4 per cent) following skin painting with
lead naphthenate whilst only a single papilloma developed in mice treated with
the whole additive formulation (additive concentrate). However, skin painting
the lead naphthenate fraction induced marked kidney damage and tubtilar
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Additive II, unlike the first preparation tested, did not induce skin ulceration
and mice tolerated twice weekly treatment. Thus when tumours were first
recorded (24 weeks) only 6 mice (10 per cent) had died or been killed (Fig. 1).
This additive also was carcinogenic inducing skin tumours in 29 (48 per cent) of
mice at risk (Table I). These tumours were mainly benign papillomata but
squamous cell carcinomata were observed in 10 mice (19 per cent).
DISCUSSION
The present findings clearly demonstrate that the base oil component of the
oil additive previously tested (Baldwin, Cunningham and Pratt, 1961) is the only
fraction with any significant carcinogenic activity. WVhilst the activities of the
base oil and whole additive were almostidentical when assessed from theincidences
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of total skin tumours, the incidence of skin carcinomata was significantly lower
in mice treated with base oil (Table I). This difference may simply be due to the
poor survival of mice treated with base oil (Fig. 1), although the possibility that
other components in the additive, e.g. halogenated hydrocarbons, possess promot-
ing properties cannot be excluded. However, the finding that the whole additive
formulation excluding the base oil and the lead naphthenate fraction were inactive
implies that components in the base oil are mainly responsible for the carcinogen-
icity of the additive.
Previously, the base oil was classified as a Venezuelan crude oil which had not
undergone thermal reforming. In view of the present findings, further character-
istics of the base oil have been provided by the manufacturers and these indicate
that it is a spindle oil. Moreover, its physical properties suggest that it falls
within the class of oils which from previous studies (Twort and Lyth, 1933;
Cook, Carruthers and Woodhouse, 1958) may be expected to be carcinogenic.
Details of the composition of the second additive (additive II) which has been
shown to be carcinogenic (Table I) are not available. However, this additive also
contains a formulation dispersed in a mineral oil base and so the possibility that
the carcinogenic substances are contained in this fraction needs to be considered.
Clearly, a larger series of oil additives and their components require to be
evaluated in order to assess the possible potential health hazard ofthese substances.
Moreover, although these experimental findings are not directly applicable to man,
in considering the effects of oil additives and also lubricating oils in general, they
need to be considered as possible atmospheric pollutants, resulting from emission
as oil particles in vehicle exhaust fumes. Whilst the amount of oily material
emitted may only be small compared to that of the petroleum combustion
products, although this will depend upon the efficiency of the engine, the high
carcinogenicity of additive I and its base oil suggests that such material may
represent a significant carcinogenic factor. Wynder and Hoffmann (1962) have
demonstrated that engine exhaust condensates, prepared so that much of the oily
material was excluded and so presumably containing mainly petroleum combus-
tion products, were carcinogenic for mouse skin. Whilst direct comparison of
these studies with the present findings is complicated by variations in experimental
procedure, the carcinogenic response elicited by additive I approximates to that
of the most potent condensate fraction.
That air pollutants represent a significant factor in environmental carcino-
genesis is now well established (Hueper et al., 1962; Falk and Kotin, 1962 ; Kotin
and Falk, 1963) and several polycyclic hydrocarbon carcinogens have been
detected in urban polluted atmospheres (Kotin and Falk, 1963). As yet however,
the significance of mineral oils as environmental carcinogens has not received
sufficient consideration although numerous studies have demonstrated carcino-
genic activity in a variety of lubricating and cutting oils (Shubik and Saffioti,
1954; Gilman and Vesselinovitch, 1956; Eckardt, 1957: Cook, Carruthers and
Woodhouse, 1958; Hueper and Payne. 1960). In considering the carcinogenicity
of petroleum derivatives, Hueper and Payne (1960) have also emphasized the
potential health hazard ofrespiratory exposure to cooling and lubricating oil mists
EXPLANATION OF PLATE
FICG. 2. Additive I base oil-induced squamous cell carcinoma with local invasion. H. & E.
x 200.
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both in special occupational groups such as metallurgical workers and also in the
population at large. However, evidence ofthe influence ofoccupational exposure
to oil mists is still inconclusive (Hendricks, Collings, Dooley, Garrett and Rather,
1962) and clearly there is a need also for a more comprehensive assessment of the
hazards of oil mist exposure.
SUMMARY
1. Examination of component fractions of a proprietary engine oil additive
previously shown to be carcinogenic for mouse skin has demonstrated that the
carcinogenic substances are contained almost exclusively in the base oil.
2. A further additive agent used mainly as an upper cylinder lubricant also
proved to be carcinogenic for mouse skin. The significance ofthe findings are dis-
cussed, particularly with regard to the possibility that these substances may be
atmospheric pollutants.
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